FDA Brief

Warning letters Drugs

FDA warning letter to

Ismar Soluciones Dinámicas S de RL de CV

High riskIssued May 4, 2021Posted May 11, 2021Center for Drug Evaluation and Research

Mexican maker Ismar's OZÓ hand sanitizer, labeled 70% ethanol, was found to contain 62% methanol; FDA refused the shipment and blocked imports.

What happened

FDA laboratory-tested a batch of OZÓ Hand Sanitizer that was detained and refused admission at the U.S. border; the label said 70% ethanol, but testing found about 1% ethanol and 62% methanol by volume. FDA held a call with the firm on August 5, 2020, and warned the public about the methanol contamination on August 6, 2020. FDA placed all drugs made by the firm on Import Alert 66-78, and the firm told FDA in January 2021 that it is out of business.

What FDA found

  1. The active ingredient ethanol was replaced wholly or in part with methanol, a dangerous chemical.

    Section 501(d)(2) of the FD&C Act, 21 U.S.C. 351(d)(2)
  2. The substitution shows the firm's quality assurance was not working as required by current good manufacturing practice (CGMP, the manufacturing quality rules for drugs).

    Section 501(a)(2)(B) of the FD&C Act, 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer is an unapproved new drug sold without FDA approval and does not meet the conditions for marketing without approval.

    Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  4. The label falsely said the product contained 70% ethanol and did not list the methanol that was actually in it.

    Sections 502(a) and 502(e)(1)(A) of the FD&C Act, 21 U.S.C. 352(a) and 352(e)(1)(A)
  5. The label did not give a U.S. address or phone number for reporting a serious adverse event.

    Section 502(x) of the FD&C Act, 21 U.S.C. 352(x)
  6. The product does not comply with the requirements for nonprescription drugs marketed without an approved application, and methanol is not a safe, suitable inactive ingredient.

    Section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee); 21 CFR 330.1(e)

What FDA wants

Respond in writing within 15 working days with an investigation into how the ethanol was replaced with methanol, a list of all raw materials and suppliers, a list of all hand sanitizer batches shipped to the U.S., and complete batch records for those batches. FDA also strongly recommends hiring a qualified CGMP consultant before making drugs for the U.S. market again.

Who should pay attention

  • distributors and retailers that bought hand sanitizer made by this firm
  • importers and brands sourcing hand sanitizer from Mexican contract manufacturers
  • companies buying raw ethanol or methanol for drug production

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk